News
BASEL, Switzerland I April 14, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Columvi® (glofitamab) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback